Michael Mangone is an accomplished professional with extensive experience in business development and operations within the biotechnology sector. Currently serving as Vice President of Business Development at Absci since February 2025, Michael previously held the role of Vice President of Corporate Development at Simcha Therapeutics from September 2022 to February 2025. Prior to that, Michael was Vice President of Business Development and Operations at BridgeBio, overseeing two portfolio companies, Phoenix Tissue Repair and Origin Biosciences, from November 2019 to February 2025. Michael’s earlier roles include Senior Consultant at ClearView Healthcare Partners and Postdoctoral Research Scientist at Columbia University Medical Center, where significant advancements were achieved in preclinical research for B-cell lymphoma therapies. Educational credentials include a PhD in Pathobiology from NYU Grossman School of Medicine and an AB in Molecular Biology from Princeton University.
This person is not in any teams
This person is not in any offices